Skip to content

ACHIEVE Hearing Intervention Follow-Up Study

Randomized Trial of Telehealth vs. Conventional Hearing Care Delivery in the ACHIEVE Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05070429
Acronym
ACHIEVE-HIFU
Enrollment
339
Registered
2021-10-07
Start date
2021-11-12
Completion date
2025-06-19
Last updated
2026-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Hearing Loss

Keywords

hearing healthcare, telehealth hearing healthcare, clinic-based hearing healthcare, hearing healthcare service delivery models

Brief summary

The ACHIEVE Hearing Intervention Follow-Up study is a randomized trial of a telehealth versus conventional clinic-based hearing healthcare (HHC) delivery model among older adults who are existing hearing aid users to determine if a telehealth HHC model improves hearing aid use and other communication outcomes compared to clinic-based HHC.

Detailed description

This study is a multi-site randomized efficacy trial of a telehealth versus conventional clinic-based hearing healthcare (HHC) delivery model among older adults who are existing hearing aid users to determine if a telehealth HHC model improves hearing aid use and other communication outcomes compared to clinic-based HHC. Participants will be recruited from the ongoing Aging & Cognitive Health Evaluation in Elders (ACHIEVE) randomized trial in which the investigators recruited 977 adults ages 70-84 with untreated mild-to-moderate hearing loss from January 2018 to October 2019 who were randomized to a hearing intervention (i.e., conventional clinic-based delivery of hearing services and technologies) versus a successful aging education control intervention (i.e., one-on-one sessions with a health educator on topics important for healthy aging). From 2021-2022, as participants in the hearing intervention group (fixed sample, n=490) complete the pre-specified three years of follow-up in the ACHIEVE trial, the investigators will recruit these existing hearing aid users and randomize the participants 1:1 to receive continued conventional clinic-based delivery of hearing care services versus a model that incorporates telehealth. Accounting for loss to follow-up and death, the investigators conservatively estimate that n=400 participants currently in the hearing intervention group will be recruited into this two-year follow-up study. The main analyses will be conducted at one-year post-randomization when hours of hearing aid use (primary outcome) and patient-centered hearing and communication, social functioning, and quality of life secondary outcomes will be contrasted between the two intervention groups. After one year of follow-up, participants randomized to the conventional HHC arm will cross-over and also receive telehealth HHC, while participants randomized to the telehealth HHC arm will continue to receive telehealth HHC. All participants will continue to be followed for 2 years post-randomization for observational analyses, with data collection follow-up visits occurring every 6 months.

Interventions

OTHERClinic-based audiological rehabilitative service delivery

Participants will have scheduled clinic-based visits at 6 and 12 months post-randomization to reinforce self-management strategies and perform hearing aid checks.

OTHERTelehealth audiological rehabilitative service delivery

Participants' scheduled clinic-based visits will be complemented with asynchronous and synchronous telehealth that will allow for routine troubleshooting of communication challenges, hearing aid technical issues, and reinforcement of self-management support strategies. At an initial session, participants will be instructed in the use of a study-provided, internet-enabled tablet device for telehealth sessions, re-introduced to the hearing loss toolkit for self-management and C2Hear Reusable Learning Objects within the context of the telehealth platform, re-evaluated on the Client Oriented Scale of Improvement (COSI) goals. Two remote follow-up sessions will be scheduled 3 and 6 weeks later to confirm participants' comfort with the telehealth platform and then completed every 6 months, in addition to scheduled 6-month clinic-based visits.

Sponsors

Johns Hopkins University
Lead SponsorOTHER
University of North Carolina
CollaboratorOTHER
University of South Florida
CollaboratorOTHER
University of Minnesota
CollaboratorOTHER
University of Mississippi Medical Center
CollaboratorOTHER
Wake Forest University
CollaboratorOTHER
National Institute on Deafness and Other Communication Disorders (NIDCD)
CollaboratorNIH
NYU Langone Health
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
73 Years to 88 Years
Healthy volunteers
No

Inclusion criteria

To be eligible for the current study, participants must: * have been eligible for and participated in the hearing intervention arm of the ACHIEVE trial (see original eligibility criteria below) * agree to be randomized to receive continued hearing care via either a telehealth or conventional delivery model, and * agree to participate in the follow-up study. Original ACHIEVE Inclusion Criteria: * Age 70-84 years * Community-dwelling, fluent English speaker * Availability of participant in area for study duration * Adult-onset hearing impairment, defined as four-frequency pure tone average (PTA, 0.5-4 kilohertz (kHz), better ear) ≥30 decibel (dB) hearing level (HL) (decibels hearing level) \& \<70 dB HL * Speech recognition scores in quiet ≥60% in better ear * Mini-Mental State Exam (MMSE) score ≥23 for participants with high school degree or less, or ≥25 for participants with some college education or more Original ACHIEVE

Exclusion criteria

* Reported disability in ≥2 activities of daily living (ADLs) * Vision impairment (worse than 20/63 on the Minnesota Near Vision Card) * Self-reported use of a hearing aid in the past 1 year * Medical contraindication to use of hearing aids (e.g., draining ear) * Unwilling to wear hearing aids on a daily basis * Conductive hearing impairment with air-bone gap \>15 dB in two or more contiguous frequencies in both ears

Design outcomes

Primary

MeasureTime frameDescription
Average Daily Hours of Hearing Aid UseUp to 1 yearAverage daily hours of hearing aid use is obtained using objective hearing aid data logging. If a participant wears a hearing aid in both ears, then the ear with the greatest number of hours will be selected.

Secondary

MeasureTime frameDescription
Treatment Satisfaction as Assessed by a Single Item From the International Outcome Inventory - Comprehensive Hearing Intervention (IOI-CHI) Scale1 yearThe IOI-CHI is an interviewer-administered scale that consists of 6 items where participants self-report satisfaction with the hearing intervention using a 5-point Likert scale; treatment satisfaction is based on the item "Considering everything, do you think your present hearing intervention is worth the trouble?"), with scores ranging from 1 to 5 and higher scores indicating more treatment satisfaction.
Ability to Hear for Primary Communication Goal as Assessed by a Single Item From the Client-Oriented Scale of Improvement (COSI) Goals Achievement Questionnaire1 yearAchievement of COSI goals will be assessed by asking participants to rate their current ability to hear for their primary goal using a 5-point Likert scale, with options 1=hardly ever (10%), 2=occasionally (25%), 3=half of the time (50%), 4=most of the time (75%), and 5=almost always (95%), where higher scores indicate greater ability to hear. Mean of participant scale choice is reported.
Hearing-specific Quality of Life as Assessed by the Hearing Handicap Inventory for the Elderly - Screening Version (HHIE-S) Questionnaire1 yearThe HHIE-S is an interviewer-administered questionnaire that consists of 10 items; participants rate whether hearing loss affects them in different situations (yes, sometimes, or no); the total score is the sum of all responses and ranges from 0 to 40, with higher scores indicating greater hearing issues.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORFrank R Lin, MD, PhD

Johns Hopkins University

PRINCIPAL_INVESTIGATORVictoria A Sanchez, AuD, PhD

University of South Florida

Participant flow

Participants by arm

ArmCount
Conventional Hearing Healthcare Group
The conventional hearing group will have clinic-based visits every 6 months for the 2-year study. During Year 1, they will receive clinic-based audiological rehabilitative service and use conventional options to address unanticipated needs. During Year 2, this group will also receive telehealth audiological rehabilitative service delivery and be able to utilize telehealth, and conventional options, to address any unanticipated needs. Clinic-based audiological rehabilitative service: Participants will have scheduled clinic-based visits at 6 and 12 months post-randomization to reinforce self-management strategies and hearing aid checks. Telehealth audiological rehabilitative service: Participants' scheduled clinic-based visits will be complemented with asynchronous and synchronous telehealth that will allow for routine troubleshooting of communication challenges, hearing aid issues, and reinforcement of self-management support strategies. At an initial session, participants will be instructed in the use of, an internet-enabled tablet device for telehealth sessions, re-introduced to the hearing loss toolkit for self-management and C2Hear Reusable Learning Objects within the context of the telehealth platform, re-evaluated on the Client Oriented Scale of Improvement goals. Two remote follow-up sessions will be scheduled 3 and 6 weeks later to confirm participants' comfort with the telehealth platform, completed every 6 months, and scheduled 6-month clinic-based visits.
176
Telehealth Hearing Healthcare Group
The telehealth hearing healthcare group will have clinic-based visits every 6 months for the duration of the 2-year study. This group will receive telehealth audiological rehabilitative service delivery and be able to utilize telehealth options, in addition to conventional options, to address any unanticipated needs that arise during both years of the study. Telehealth audiological rehabilitative service delivery: Participants' scheduled clinic-based visits will be complemented with asynchronous and synchronous telehealth that will allow for routine troubleshooting of communication challenges, hearing aid technical issues, and reinforcement of self-management support strategies. At an initial session, participants will be instructed in the use of a study-provided, internet-enabled tablet device for telehealth sessions, re-introduced to the hearing loss toolkit for self-management and C2Hear Reusable Learning Objects within the context of the telehealth platform, re-evaluated on the Client Oriented Scale of Improvement (COSI) goals. Two remote follow-up sessions will be scheduled 3 and 6 weeks later to confirm participants' comfort with the telehealth platform and then completed every 6 months, in addition to scheduled 6-month clinic-based visits.
163
Total339

Baseline characteristics

CharacteristicTelehealth Hearing Healthcare GroupConventional Hearing Healthcare GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
163 Participants176 Participants339 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous79.1 years
STANDARD_DEVIATION 4
78.7 years
STANDARD_DEVIATION 3.8
78.9 years
STANDARD_DEVIATION 3.9
Age, Customized
Age in Categories
75 - 79 years
65 Participants82 Participants147 Participants
Age, Customized
Age in Categories
80 - 84 years
56 Participants53 Participants109 Participants
Age, Customized
Age in Categories
85 - 88 years
20 Participants14 Participants34 Participants
Age, Customized
Age in Categories
Between 72 and 74 years
22 Participants27 Participants49 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants1 Participants4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
158 Participants170 Participants328 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants5 Participants7 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Asian
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
18 Participants17 Participants35 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
145 Participants157 Participants302 Participants
Region of Enrollment
United States
163 Participants176 Participants339 Participants
Sex: Female, Male
Female
87 Participants99 Participants186 Participants
Sex: Female, Male
Male
76 Participants77 Participants153 Participants
Site
Forsyth County, NC
35 Participants37 Participants72 Participants
Site
Jackson, MS
39 Participants45 Participants84 Participants
Site
Minneapolis, MN
42 Participants43 Participants85 Participants
Site
Washington County, MD
47 Participants51 Participants98 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1764 / 163
other
Total, other adverse events
7 / 17611 / 163
serious
Total, serious adverse events
0 / 1760 / 163

Outcome results

Primary

Average Daily Hours of Hearing Aid Use

Average daily hours of hearing aid use is obtained using objective hearing aid data logging. If a participant wears a hearing aid in both ears, then the ear with the greatest number of hours will be selected.

Time frame: Up to 1 year

ArmMeasureValue (MEAN)Dispersion
Conventional Hearing Healthcare GroupAverage Daily Hours of Hearing Aid Use7.37 Daily hoursStandard Deviation 5.15
Telehealth Hearing Healthcare GroupAverage Daily Hours of Hearing Aid Use7.20 Daily hoursStandard Deviation 5.05
Comparison: Used a weighted regression model with an identity link to compare average daily hours of hearing aid use at one-year post-randomization between participants assigned to the telehealth HHC or conventional HHC. Inverse probability of treatment weights will be calculated and included in the model for the primary outcome.p-value: 0.9295% CI: [-0.727, 0.657]generalized linear model (GLM)
Secondary

Ability to Hear for Primary Communication Goal as Assessed by a Single Item From the Client-Oriented Scale of Improvement (COSI) Goals Achievement Questionnaire

Achievement of COSI goals will be assessed by asking participants to rate their current ability to hear for their primary goal using a 5-point Likert scale, with options 1=hardly ever (10%), 2=occasionally (25%), 3=half of the time (50%), 4=most of the time (75%), and 5=almost always (95%), where higher scores indicate greater ability to hear. Mean of participant scale choice is reported.

Time frame: 1 year

ArmMeasureValue (MEAN)Dispersion
Conventional Hearing Healthcare GroupAbility to Hear for Primary Communication Goal as Assessed by a Single Item From the Client-Oriented Scale of Improvement (COSI) Goals Achievement Questionnaire4.25 score on a scaleStandard Deviation 0.74
Telehealth Hearing Healthcare GroupAbility to Hear for Primary Communication Goal as Assessed by a Single Item From the Client-Oriented Scale of Improvement (COSI) Goals Achievement Questionnaire4.29 score on a scaleStandard Deviation 0.69
Comparison: Used a weighted regression model with an identity link to compare primary COSI goal achievement at one-year post-randomization between participants assigned to the telehealth HHC or conventional HHC. Inverse probability of treatment weights will be calculated and included in the model for the secondary outcome.p-value: 0.6695% CI: [-0.201, 0.32]generalized linear model (GLM)
Secondary

Hearing-specific Quality of Life as Assessed by the Hearing Handicap Inventory for the Elderly - Screening Version (HHIE-S) Questionnaire

The HHIE-S is an interviewer-administered questionnaire that consists of 10 items; participants rate whether hearing loss affects them in different situations (yes, sometimes, or no); the total score is the sum of all responses and ranges from 0 to 40, with higher scores indicating greater hearing issues.

Time frame: 1 year

ArmMeasureValue (MEAN)Dispersion
Conventional Hearing Healthcare GroupHearing-specific Quality of Life as Assessed by the Hearing Handicap Inventory for the Elderly - Screening Version (HHIE-S) Questionnaire7.33 units on a scaleStandard Deviation 7.1
Telehealth Hearing Healthcare GroupHearing-specific Quality of Life as Assessed by the Hearing Handicap Inventory for the Elderly - Screening Version (HHIE-S) Questionnaire7.16 units on a scaleStandard Deviation 6.49
Comparison: Used a weighted regression model with an identity link to compare hearing-specific quality of life at one-year post-randomization between participants assigned to the telehealth HHC or conventional HHC. Inverse probability of treatment weights will be calculated and included in the model for the secondary outcome.p-value: 0.3895% CI: [-6.349, 2.435]generalized linear model (GLM)
Secondary

Treatment Satisfaction as Assessed by a Single Item From the International Outcome Inventory - Comprehensive Hearing Intervention (IOI-CHI) Scale

The IOI-CHI is an interviewer-administered scale that consists of 6 items where participants self-report satisfaction with the hearing intervention using a 5-point Likert scale; treatment satisfaction is based on the item Considering everything, do you think your present hearing intervention is worth the trouble?), with scores ranging from 1 to 5 and higher scores indicating more treatment satisfaction.

Time frame: 1 year

ArmMeasureValue (MEAN)Dispersion
Conventional Hearing Healthcare GroupTreatment Satisfaction as Assessed by a Single Item From the International Outcome Inventory - Comprehensive Hearing Intervention (IOI-CHI) Scale4.78 score on a scaleStandard Deviation 0.47
Telehealth Hearing Healthcare GroupTreatment Satisfaction as Assessed by a Single Item From the International Outcome Inventory - Comprehensive Hearing Intervention (IOI-CHI) Scale4.78 score on a scaleStandard Deviation 0.44
Comparison: Used a weighted regression model with an identity link to compare treatment satisfaction at one-year post-randomization between participants assigned to the telehealth HHC or conventional HHC. Inverse probability of treatment weights will be calculated and included in the model for the secondary outcome.p-value: 0.8795% CI: [-0.147, 0.125]generalized linear model (GLM)
Other Pre-specified

Average Daily Hours of Hearing Aid Use Through Two Years of Follow-up

Average daily hours of hearing aid use is obtained using objective hearing aid data logging. If a participant wears a hearing aid in both ears, then the ear with the greatest number of hours will be selected.

Time frame: Up to 2 years

Source: ClinicalTrials.gov · Data processed: Jun 12, 2026